Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · Massachusetts | Vitreoretinal surgery · New York | |
|---|---|---|
| Surgeons, 2024 | 29 | 42 |
| Medicare fee-for-service cases | 1,871 | 3,504 |
| Growth since 2019 (Medicare FFS) | −4.2%/yr | −3.3%/yr |
| Forecast cases (Medicare FFS) | 2,190 in 2030 | 3,660 in 2030 |
| Forecast growth | +2.6%/yr to 2030 | +0.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.0 | 1.9 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 38% (+4 pts since 2019) | 48% (+15 pts since 2019) |
| Cases per surgeon | 65 | 83 |
| Top 10 surgeons' share | 54% | 43% |
| Surgeons growing | 4 | 6 |
| New since the base year | 4 | 5 |
| Likely to stop billing it | 3 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $4,731 | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.